Gentium S.p.A. Provides Update on Re-Examination of Defibrotide MAA to EMA
6/4/2013 9:37:53 AM
More...
|
Gentium S.p.A. Reports First Quarter Financial Results
5/14/2013 9:13:45 AM
More...
|
Gentium S.p.A. Announces Resignation of Board Member
3/29/2013 10:15:13 AM
More...
|
Gentium S.p.A. Reports Fourth Quarter and Year End 2012 Financial Results
3/28/2013 10:37:09 AM
More...
|
Gentium S.p.A. Receives Negative Opinion From the CHMP on Defibrotide for the Treatment and Prevention of VOD
3/22/2013 9:54:14 AM
More...
|
Gentium S.p.A. Negative on Defibrotide
2/21/2013 8:02:26 AM
More...
|
Gentium S.p.A. Provides an Update on Defibrotide MAA to European Medicines Agency
1/17/2013 9:11:27 AM
More...
|
Gentium S.p.A. Submit 2nd LoOIs Response to the European Medicines Agency's CHMP for Defibrotide MAA
12/18/2012 8:54:58 AM
More...
|
Results From Gentium S.p.A.'s Treatment IND for Defibrotide Presented at the American Society of Hematology Annual Meeting
12/13/2012 9:50:42 AM
More...
|
Gentium S.p.A. Release: Data From Non HSCT VOD Patients Treated With Defibrotide and a Treatment IND Update to be Presented at the American Society of Hematology Annual Meeting
12/7/2012 9:46:19 AM
More...
|
|